1,815
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Targeting SARS-CoV-2 Using Polycomb Inhibitors as Antiviral Agents

&
Pages 811-812 | Received 14 Apr 2020, Accepted 17 Apr 2020, Published online: 04 Jun 2020

References

  • Neher RA , DyrdakR , DruelleV , HodcroftEB , AlbertJ. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. Swiss Med. Wkly.150w20224 (2020).
  • Group CC-19 W . DaviesNG , KucharskiAJ , EggoRM , GimmaA , EdmundsWJ. The effect of non-pharmaceutical interventions on COVID-19 cases, deaths and demand for hospital services in the UK: A modelling study. medRxiv.https://doi.org/10.1101/2020.04.01.20049908 (2020) ( Epub ahead of print).
  • Lurie N , SavilleM , HatchettR , HaltonJ. Developing Covid-19 Vaccines at Pandemic Speed. N. Engl. J. Med.doi: 10.1056/NEJMp2005630 (2020) ( Epub ahead of print).
  • Yang Y , ShenC , LiJet al. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. medRxiv.https://doi.org/10.1101/2020.03.02.20029975 (2020) ( Epub ahead of print).
  • Wang M , CaoR , ZhangLet al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res.30(3), 269–971 (2020).
  • Menachery VD , EisfeldAJ , SchäferAet al. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. MBio5(3), e01174 (2014).
  • Burr ML , SparbierCE , ChanKLet al. An evolutionarily conserved function of polycomb silences the MHC Class I antigen presentation pathway and enables immune evasion in cancer. Cancer Cell.36(4), 385–401.e8 (2019).
  • Tremblay-Lemay R , RastgooN , PourabdollahM , ChangH. EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies. Biomark. Res.6(1), 34 (2018). https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-018-0148-5
  • Chen S , ShengC , LiuDet al. Enhancer of zeste homolog 2 is a negative regulator of mitochondria-mediated innate immune responses. J. Immunol.191(5), 2614–4623 (2013).
  • Arbuckle JH , GardinaPJ , GordonDNet al. Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens. MBio8(4), e01141–17 (2017).
  • Yin J , LeavenworthJW , LiYet al. Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity. Proc. Natl Acad. Sci. USA112(52), 15988–85993 (2015).
  • Brandstadter JD , YangY. Natural killer cell responses to viral infection. J. Innate Immun.3(3), 274–479 (2011).
  • Nutt SL , KeenanC , ChopinM , AllanRS. EZH2 function in immune cell development. Biol. Chem.doi: 10.1515/hsz-2019-0436 (2020) ( Epub ahead of print).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.